Feed KNBIF
KN
Kane Biotech Inc.
KNBIF · OTC
$0.01 -20.33% (-$0.00)
1M +0.00%
Market Cap $4.1M
P/E Ratio -
Div. Yield -
ROE -
Valuation
0 /100
Expensive P/S 70.95x
P/E N/A
EV/EBITDA N/A
Growth
0 /100
Declining Rev. growth 45.69%
EPS growth N/A
FCF growth N/A
Profitability
0 /100
Weak Gross margin 391.95%
Net margin 3,800.74%
Op. margin 4,504.56%
Quality
1 /100
Poor ROIC 501.95%
ROA 122.12%
Asset turnover 0.03x
Debt
1 /100
High Current ratio 0.45x
Int. coverage -10.87x
Debt/Equity N/A
Stability
32 /100
Unstable Beta 0.31x
Rev. volatility 798.91%
EPS volatility 22.98%
Întreabă StockBot despre KNBIF
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Robert Huizinga
Employees
20
Headquarters
Winnipeg
Evenimente viitoare
27 AUG.
Earnings
Upcoming earnings report